Akoya Biosciences’ $43.5 Million Common Stock Offering

Laura Testa North America Legal Chronicle
Tagged:

DLA Piper advised Akoya Biosciences on the deal.Akoya Biosciences (Akoya), a leading biotechnology company that specializes in the development and commercialization of spatial biology solutions, announced…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here